ASI-Improving Patient Care Through Superior Imaging Analysis
Applied Spectral Imaging (ASI) makes patient care better through advanced biomedical microscopy imaging.
The GenASIs™ automated imaging platforms for genetic and pathology analysis provide state of the art diagnostic aids for pathologists and cytogeneticists, with reproducible and reliable results. GenASIs Hyperspectral with HiSKY® Probes provide superb biomedical analyses surpassing the abilities of normal human vision.
The GenASIs platform is FDA cleared for BandView Karyotyping, FISHView, SpotScan for CEP XY, UroVysion, ALK and HER2/neu FISH, and HiPath for IHC Family: HER2, ER, PR, and Ki67.
ASI, the industry's leading microscopy imaging solution provider since 1993, has dozens of registered patents in the US, Europe and Japan and thousands of systems deployed worldwide. ASI has worldwide offices in the US, Europe and Asia and a global network of distributors.